THE AGONIST PROPERTIES OF META-CHLOROPHENYLBIGUANIDE AND 2-METHYL-5-HYDROXYTRYPTAMINE ON 5-HT3 RECEPTORS IN N1E-115 NEUROBLASTOMA-CELLS

被引:71
作者
SEPULVEDA, MI
LUMMIS, SCR
MARTIN, IL
机构
[1] Molecular Neurobiology Unit, MRC Centre, Cambridge, CB2 2QH, Hills Road
关键词
5-HT3; RECEPTOR; N1E-115 NEUROBLASTOMA CELLS; PARTIAL AGONIST; AGONIST; 2-METHYL-5-HT; META-CHLOROPHENYLBIGUANIDE; 5-HYDROXYTRYPTAMINE;
D O I
10.1111/j.1476-5381.1991.tb12464.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of 5-HT3 selective agonists have been studied in whole-cell voltage-clamped N1E-115 neuroblastoma cells. 2 Application of 5-hydroxytryptamine (5-HT) results in the rapid development of a transient inward current at quasiphysiological membrane potentials. This current can be blocked by the 5-HT3 specific antagonists BRL 43694 and GR67330. 3 Application of 2-methyl-5-HT (2-Me5-HT), a 5-HT3 selective agonist, produced a qualitatively similar inward current, but with a maximum response only 20% of that produced by 5-HT. 4 In the presence of 100-mu-M 2-Me5-HT, the upper part of the 5-HT dose-response curve was shifted to the right but reached the same maximum value as in the absence of 2-Me5-HT. 2-Me5-HT appears therefore to be a partial agonist under these conditions. 5 The novel 5-HT3 agonist, meta-chlorophenylbiguanide (mCPBG) is a full agonist, but has a Hill coefficient (1.5) significantly less than that of 5-HT (2.3). 6 Comparison with radioligand binding data show that mCBPG is 100 times less potent than expected; it may therefore exhibit a high affinity for a desensitized state.
引用
收藏
页码:536 / 540
页数:5
相关论文
共 23 条
[1]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576
[2]  
BRISTOW DR, 1989, EUR J PHARMACOL, V73, P65
[3]   THE NICOTINIC ACETYLCHOLINE-RECEPTOR - MOLECULAR ARCHITECTURE OF A LIGAND-REGULATED ION CHANNEL [J].
CHANGEUX, JP ;
GIRAUDAT, J ;
DENNIS, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (12) :459-465
[4]  
COSTALL B, 1987, NEUROSCI LETT S, V29, pS69
[5]   5-HT3 RECEPTORS ARE MEMBRANE ION CHANNELS [J].
DERKACH, V ;
SURPRENANT, A ;
NORTH, RA .
NATURE, 1989, 339 (6227) :706-709
[6]  
HALES TG, 1988, BRIT J PHARMACOL, V94, pP393
[7]   IMPROVED PATCH-CLAMP TECHNIQUES FOR HIGH-RESOLUTION CURRENT RECORDING FROM CELLS AND CELL-FREE MEMBRANE PATCHES [J].
HAMILL, OP ;
MARTY, A ;
NEHER, E ;
SAKMANN, B ;
SIGWORTH, FJ .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1981, 391 (02) :85-100
[8]   PHARMACOLOGICAL CHARACTERIZATION OF 5-HYDROXYTRYPTAMINE-INDUCED DEPOLARIZATION OF THE RAT ISOLATED VAGUS NERVE [J].
IRELAND, SJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (01) :229-238
[9]   THE POTENTIAL ANXIOLYTIC ACTIVITY OF GR38032F, A 5-HT3-RECEPTOR ANTAGONIST [J].
JONES, BJ ;
COSTALL, B ;
DOMENEY, AM ;
KELLY, ME ;
NAYLOR, RJ ;
OAKLEY, NR ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) :985-993
[10]   1-(M-CHLOROPHENYL)-BIGUANIDE, A POTENT HIGH-AFFINITY 5-HT3 RECEPTOR AGONIST [J].
KILPATRICK, GJ ;
BUTLER, A ;
BURRIDGE, J ;
OXFORD, AW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 182 (01) :193-197